| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/27/2011 | CN101565405B Sulfamethazine antigen, preparation method and application thereof |
| 07/27/2011 | CN101497653B Small peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 07/27/2011 | CN101481419B Fusion protein of beta 2-microglobulin and green fluorescent protein, preparation and use thereof |
| 07/27/2011 | CN101430307B Method for simultaneously analyzing amino acid and organic acid metabolite spectrum |
| 07/27/2011 | CN101419144B Micro-crack on site concrete strength detecting method and implementing device thereof |
| 07/27/2011 | CN101367876B Monoclonal antiidiotypic antibody NP30 single-specificity double-chain antibody of Japanese blood fluke, preparation method and uses thereof |
| 07/27/2011 | CN101339135B Method for promoting biological detection sensitivity by photon crystal |
| 07/27/2011 | CN101319998B Urinalysis reagent for screening malignant galactophore disease and application thereof |
| 07/27/2011 | CN101285820B Inverse opal structural membrane purpose |
| 07/27/2011 | CN101191787B High performance liquid chromatography method for measuring doripenem content |
| 07/27/2011 | CN101183093B Measuring equipment of non-metallic material high-temperature expansive power and method of use thereof |
| 07/27/2011 | CN101165486B Micro fluid control array protein chip and its usage method |
| 07/27/2011 | CN101118235B Measurement mechanism for trace quantity electric charge and method thereof |
| 07/27/2011 | CN101017176B Method for detecting small and dense low density lipoprotein with microflow hole chip electrophoretic separation |
| 07/27/2011 | CN101004415B Method for measuring drug fast variation of hepatitis b virus to Adefovir |
| 07/26/2011 | USRE42567 Electrochemical cell |
| 07/26/2011 | US7987055 Body fat measurement device and body fat measurement result providing method |
| 07/26/2011 | US7985874 Supports react with aldehyde groups of sugars; purification of sugars |
| 07/26/2011 | US7985854 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
| 07/26/2011 | US7985842 Anti-IGF-I receptor antibody |
| 07/26/2011 | US7985841 Heterodimeric receptor libraries using phagemids |
| 07/26/2011 | US7985840 Polypeptide fusion comprising complementary determining regions for use as tool in immunotherapeutic and/or diagnostics; bioassay |
| 07/26/2011 | US7985834 Compositions and methods for increasing bone mineralization |
| 07/26/2011 | US7985739 Generating transgenic cells via insertional event generated by modified transposase; mobile genetic element for use as tool in heterologous gene transfer |
| 07/26/2011 | US7985602 Fluorescent dye compounds, conjugates and uses thereof |
| 07/26/2011 | US7985601 Drug delivery vehicle; tissue engineering |
| 07/26/2011 | US7985600 Use of perfluoropolymers in the determination of the receptor-ligand binding constant |
| 07/26/2011 | US7985599 Microfluidic platform of arrayed switchable spin-valve elements for high-throughput sorting and manipulation of magnetic particles and biomolecules |
| 07/26/2011 | US7985598 Biomolecule-immobilized plate and method for fabricating biomolecule-immobilized plate |
| 07/26/2011 | US7985592 High throughput screening methods for lubricating oil compositions |
| 07/26/2011 | US7985591 Dirofilaria cuticle protein for use in identifying modulators and preparing vaccines for prevention and treatment worm infection |
| 07/26/2011 | US7985589 Quantification of analytes using accelerator mass spectrometry |
| 07/26/2011 | US7985587 Methods of culturing dermal papilla cells |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | US7985562 Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism |
| 07/26/2011 | US7985561 Manganese superoxide dismutase Val16Ala polymorphism predicts resistance to chemotherapeutic drug cancer therapy |
| 07/26/2011 | US7985560 Methods and compositions for monitoring and risk prediction in cardiorenal syndrome |
| 07/26/2011 | US7985559 Methods of selecting epidermal growth factor receptor (EGFR) binding agents |
| 07/26/2011 | US7985558 Methods for diagnosis of cardiovascular disease |
| 07/26/2011 | US7985557 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 07/26/2011 | US7985556 Method of screening apoptosis accelerating compound or anti-apoptotic compound and method of determining malignancy of neurodegenerative disease |
| 07/26/2011 | US7985555 Using monospecific immunoglobulins as diagnostic/prognostic tool in detecting nervous system disorders |
| 07/26/2011 | US7985554 Botulinum neurotoxin A receptor and the use thereof |
| 07/26/2011 | US7985552 Dye conjugates of nucleotides and other biological substances |
| 07/26/2011 | US7985549 Method for predicting responsiveness to TNFα blocking agents |
| 07/26/2011 | US7985539 Comprises oligonucleotide sequences conjugated to raman labels for highly sensitive and highly selective detection of target sequences in solution; genomics and proteomics |
| 07/26/2011 | US7985538 Drug resistance and methods of reversing |
| 07/26/2011 | US7985386 Implantable medical device for diagnostic sensing |
| 07/26/2011 | US7985384 Analysis kit for living organism and chemical reaction |
| 07/26/2011 | US7985376 Measuring unit and rotary valve for use therein |
| 07/26/2011 | US7985340 Magnetic separator |
| 07/26/2011 | US7984643 Process for evaluating fouling caused by refinery feedstocks |
| 07/26/2011 | US7984641 Method and test fixture for evaluating a lubrication containment system |
| 07/26/2011 | CA2784919A1 Compositions and methods relating to argininosuccinate synthetase |
| 07/26/2011 | CA2633354C Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy |
| 07/26/2011 | CA2487976C Calcitonin gene related peptide receptor antagonists |
| 07/26/2011 | CA2485697C Systems and methods for analyzing target contrast features in images of biological samples |
| 07/26/2011 | CA2474853C Methods, devices, and systems using acoustic ejection for depositing fluid droplets on a sample surface for analysis |
| 07/26/2011 | CA2461571C Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 07/26/2011 | CA2453528C Novel fusion proteins and assays for molecular binding |
| 07/26/2011 | CA2446502C High capacity assay platforms |
| 07/26/2011 | CA2441225C A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 07/26/2011 | CA2439679C Method for assaying non-spermine/spermidine activity of spermidine/spermine n1-acetyltransferase (ssat) |
| 07/26/2011 | CA2432995C Immunogenic hla-a2 supermotif-restricted peptides |
| 07/26/2011 | CA2430750C High spatial resolution matrix assisted laser desorption/ionization (maldi) |
| 07/26/2011 | CA2411249C Gasc1 gene |
| 07/26/2011 | CA2391045C Device for receiving a chip shaped carrier and process for assembling a plurality of such devices |
| 07/26/2011 | CA2389220C Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population |
| 07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 07/26/2011 | CA2352467C Apoptosis-inducing factor |
| 07/26/2011 | CA2299677C Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 07/26/2011 | CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/25/2011 | CA2738525A1 Mass spectrometry-based protein identification |
| 07/21/2011 | WO2011088476A1 Rick factors of cigarette smoke-induced spirometric phenotypes |
| 07/21/2011 | WO2011088431A1 Prophylactic and treatment for virus-induced disease |
| 07/21/2011 | WO2011088322A1 Treatment of diabetes and disorders associated with visceral obesity with inhibitors of human arachidonate 12 lipoxygenase and arachidonate 15-lipoxygenase |
| 07/21/2011 | WO2011088314A1 Method for determining volume and hemoglobin content of individual red blood cells |
| 07/21/2011 | WO2011088247A1 In situ-dilution method and system for measuring molecular and chemical interactions |
| 07/21/2011 | WO2011088225A1 Surface neutralization of apatite |
| 07/21/2011 | WO2011088163A1 Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination |
| 07/21/2011 | WO2011088098A1 Computer-implemented models predicting outcome variables and characterizing more fundamental underlying conditions |
| 07/21/2011 | WO2011088077A1 Successive sampling device and associated method |
| 07/21/2011 | WO2011088030A1 Disease diagnosis and treatment using computational molecular phenotyping |
| 07/21/2011 | WO2011087926A1 A CUT-POINT IN PTEN PROTEIN EXPRESSION THAT ACCURATELY IDENTIFIES TUMORS AND IS PREDICTIVE OF DRUG RESPONSE TO A PAN-ErbB INHIBITOR |
| 07/21/2011 | WO2011087868A1 Insulin-like growth factor 1 receptor (igf-1r) protein srm/mrm assay |
| 07/21/2011 | WO2011087865A1 Epidermal growth factor receptor (egfr) protein srm/mrm assay |
| 07/21/2011 | WO2011087646A1 Automated developer for immuno-stained biological samples |
| 07/21/2011 | WO2011087525A1 Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population |
| 07/21/2011 | WO2011087524A1 Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin |
| 07/21/2011 | WO2011087523A1 Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin |
| 07/21/2011 | WO2011087432A1 Method for analysis of proteins |
| 07/21/2011 | WO2011087367A1 Improved method for the detection of polyunsaturated fatty acids |
| 07/21/2011 | WO2011087092A1 Anti-influenza antibody and influenza detection device |
| 07/21/2011 | WO2011087091A1 Anti-asct2 (system asc amino acid transporter type 2) antibody |
| 07/21/2011 | WO2011087009A1 Regulatory gene controlling saccharometabolism, lipid metabolism, obesity and life, protein, and screening method |
| 07/21/2011 | WO2011086973A1 Antibody specific to activated egfr |
| 07/21/2011 | WO2011086840A1 Photo-sensitive gene expression regulation system |
| 07/21/2011 | WO2011086535A1 Method for assessing the effectiveness of anti-vector control strategies in the control of malaria and arbovirosis |
| 07/21/2011 | WO2011086527A1 Apparatus and method for automatic positioning cigarette paper and measuring its permeability |